Our Pipeline

Through our innovative research and a patient-centered approach, PharmaIN is shaping the future of self-injectable therapies for advanced liver cirrhosis and cancer

Drug

Indications

Discovery

Pre-clinical

Phase 1

Phase 2-3

Commercial rights

PHIN-214*

Progression of decompensated cirrhosis

Undisclosed molecule

Solid tumors

*Ongoing Phase 1 clinical trial in patients with advanced liver cirrhosis

*Ongoing Phase 1 clinical trial in patients with advanced liver cirrhosis